JP2013091632A - Involucrin expression promoter - Google Patents

Involucrin expression promoter Download PDF

Info

Publication number
JP2013091632A
JP2013091632A JP2011236255A JP2011236255A JP2013091632A JP 2013091632 A JP2013091632 A JP 2013091632A JP 2011236255 A JP2011236255 A JP 2011236255A JP 2011236255 A JP2011236255 A JP 2011236255A JP 2013091632 A JP2013091632 A JP 2013091632A
Authority
JP
Japan
Prior art keywords
involucrin
extract
hair
expression
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011236255A
Other languages
Japanese (ja)
Other versions
JP5858727B2 (en
Inventor
Naoki Oya
直樹 大矢
Akiyo Kameyama
明代 亀山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2011236255A priority Critical patent/JP5858727B2/en
Publication of JP2013091632A publication Critical patent/JP2013091632A/en
Application granted granted Critical
Publication of JP5858727B2 publication Critical patent/JP5858727B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an involucrin expression promoter capable of promoting expression of involucrin, a horny layer formation promoter, a humectant, a hair waving agent and a skin care external preparation.SOLUTION: In an involucrin expression promotor, a horny layer formation promoter, a humectant, a hair waving agent and a skin care external preparation, Veronica didyma var. lilacina or an extract therefrom is used as an active ingredient.

Description

本発明は、インボルクリンの発現を促進する、インボルクリン発現促進剤、角層形成促進剤、保湿剤、毛髪ウェーブ化剤、皮膚外用剤に関する。   The present invention relates to an involucrin expression promoting agent, a stratum corneum formation promoting agent, a moisturizing agent, a hair waving agent, and a skin external preparation that promotes the expression of involucrin.

インボルクリンは、表皮角化細胞の分化にしたがって有棘細胞で産生されるタンパク質で、角質細胞の細胞膜を裏打ちする強靭な不溶性膜であるコーニファイドエンベロープ(角質肥厚膜、cornified envelope:以下CEとも略記する)の主構成要素の1つである(非特許文献1)。CEは、インボルクリンをはじめとする複数のCE前駆体タンパク質が、酵素トランスグルタミナーゼにより架橋され不溶化して形成される。さらに、CEを構成するインボルクリンは、その一部にセラミド等の脂質が共有結合し、疎水的な構造をとることで細胞間脂質ラメラ構造の形成にも寄与している(非特許文献2)。こうしたCEの形成・成熟化によって、細胞間脂質のラメラ構造が安定化して角質層のバリア機能が正常に働き、皮膚の水分保持機能や外部からの刺激に対する抵抗性を高めることができる。
したがって、表皮細胞においてインボルクリンの発現が促進されれば、表皮細胞の角化が促進され、健全な角層の形成を促して、外界からの刺激や生体を防御するための角層バリア機能を健全に保つことができ、その結果、皮膚の水分保持能改善、毛穴目立ちの予防改善、しわの形成やきめ模様の減少等の皮膚老化の予防改善を図ることができると考えられている。
Involucrin is a protein produced in spinous cells according to the differentiation of epidermal keratinocytes, and is a strong insoluble membrane that lines the cell membrane of keratinocytes (cornified envelope; hereinafter also abbreviated as CE). ) Is one of the main components (Non-Patent Document 1). CE is formed by cross-linking and insolubilizing multiple CE precursor proteins including involucrin with the enzyme transglutaminase. Furthermore, involucrin that constitutes CE contributes to the formation of an intercellular lipid lamellar structure by covalently binding a lipid such as ceramide to a part of the involucrin (Non-patent Document 2). Such CE formation / maturation stabilizes the lamellar structure of the intercellular lipid, and the barrier function of the stratum corneum works normally, thereby enhancing the moisture retention function of the skin and the resistance to external stimuli.
Therefore, if involucrin expression is promoted in epidermal cells, the keratinization of epidermal cells is promoted, and the formation of a healthy stratum corneum is promoted, and the stratum corneum barrier function for protecting external stimuli and living bodies is healthy. As a result, it is considered that improvement of skin aging such as improvement of water retention ability of skin, prevention of pore conspicuousness, formation of wrinkles and reduction of texture pattern can be achieved.

また最近、本出願人は、毛髪形状と毛髪毛根部における各種遺伝子の遺伝子発現との関係を探索したところ、非くせ毛者の毛根部に比して、くせ毛者の毛根部において、インボルクリン(IVL)遺伝子の発現量が有意に増加しており、インボルクリンの発現を制御することにより、くせ毛を抑制したり、促進できることを報告している(特許文献1)。   Recently, the present applicant has searched for the relationship between the hair shape and the gene expression of various genes in the hair root, and found that involcrine (IVL) in the hair root of a non-hairy person compared to the hair root part of the hairless person. It has been reported that the expression level of the gene is significantly increased, and it is possible to suppress or promote comb hair by controlling the expression of involucrin (Patent Document 1).

従来、インボルクリンの発現を促進する成分としては、例えば、オトギリソウ科(Guttiferrae)のセイロンテツボク(Mesua Ferrea L.)(特許文献2)やアンズタケ属のクロラッパタケ(Craterellus cornucopioides)(特許文献3)等が報告され、インボルクリンの発現促進作用を通じてCE形成効果が期待できることが開示されている。   Conventionally, examples of components that promote the expression of involucrin include Mesua Ferrea L. (patent document 2) of the Guttiferrae family, Craterellus cornucopioides (patent document 3), and the like. It has been reported that the CE formation effect can be expected through the action of promoting the expression of involucrin.

一方、イヌノフグリ(Veronica didyma Tenore)は、ゴマノハグサ科クワガタソウ属の越年草で、鎮痛、解毒作用があることが知られているが、インボルクリン発現促進作用、角層形成促進作用、毛髪ウェーブ化作用があることは知られていない。   On the other hand, it is known that Veronica didyma Tenore is a perennial plant belonging to the genus Sphagnum, which has analgesic and detoxifying effects. However, it promotes involcrine expression, promotes stratum corneum formation, and acts as a hair wave. It is not known that there is.

国際公開第2011/043330号パンフレットInternational Publication No. 2011/043330 Pamphlet 特開2005−213187号公報JP 2005-213187 A 特開2005−89389号公報JP 2005-89389 A

Steinert, PM. Et al., J. Biol. Chem., 270(30), p17702-17711 (1995)Steinert, PM. Et al., J. Biol. Chem., 270 (30), p17702-17711 (1995) Nemes, Z., Proc. Natl. Acad. Sci. USA, 96(15), p8402-8407 (1999)Nemes, Z., Proc. Natl. Acad. Sci. USA, 96 (15), p8402-8407 (1999)

本発明は、インボルクリンの発現を促進する、インボルクリン発現促進剤、角層形成促進剤、毛髪ウェーブ化剤、皮膚外用剤を提供することに関する。   The present invention relates to providing an involucrin expression promoting agent, a stratum corneum formation promoting agent, a hair waving agent, and a skin external preparation, which promote the expression of involucrin.

本発明者らは、インボルクリンの発現促進について検討したところ、ゴマノハグサ科の植物であるイヌノフグリの抽出物に優れたインボルクリン発現促進作用があり、これがインボルクリン発現促進、角層形成促進、皮膚の水分保持能の改善、毛髪ウェーブ化のための成分又は素材として有用であることを見出した。   The inventors of the present invention examined involucrin expression promotion. As a result, an extract of Inohokuguri, which is a plant of the genus Ligaceae, has an excellent involucrin expression promoting action, which promotes involucrin expression, promotes stratum corneum formation, and retains skin moisture It was found to be useful as a component or material for improvement of hair and hair waving.

すなわち、本発明は、下記の1)〜5)に係るものである。
1)イヌノフグリ又はその抽出物を有効成分とするインボルクリン発現促進剤。
2)イヌノフグリ又はその抽出物を有効成分とする角層形成促進剤。
3)イヌノフグリ又はその抽出物を有効成分とする保湿剤。
4)イヌノフグリ又はその抽出物を有効成分とする毛髪ウェーブ化剤。
5)イヌノフグリ又はその抽出物を含有する皮膚外用剤。
That is, the present invention relates to the following 1) to 5).
1) An involucrin expression promoter containing inofugururi or an extract thereof as an active ingredient.
2) A stratum corneum formation promoting agent comprising inofuguri or an extract thereof as an active ingredient.
3) A moisturizing agent containing inofugururi or an extract thereof as an active ingredient.
4) A hair waving agent containing inuvenufu or an extract thereof as an active ingredient.
5) An external preparation for skin containing Inufuguri or an extract thereof.

本発明によれば、インボルクリンの産生促進能力を有し、角層細胞の角化を促進し、健全な角層の形成を促すことで、皮膚バリア機能を健全にすることができる化粧品、医薬品又は医薬部外品、毛髪をウェーブ化するための化粧品、医薬部外品等を提供することができる。   According to the present invention, a cosmetic, pharmaceutical or pharmaceutical product that has the ability to promote the production of involucrin, promotes cornification of horny cells, and promotes the formation of a healthy horny layer, thereby making the skin barrier function sound. Quasi-drugs, cosmetics for waving hair, quasi-drugs and the like can be provided.

インボリクリンの発現促進効果を示すグラフ。The graph which shows the expression promotion effect of inboliclin.

本発明において、イヌノフグリとは、ゴマノハグサ科クワガタソウ属のイヌノフグリ(Veronica didyma Tenore)を意味する。
イヌノフグリは、葉、茎、芽、花、種子、果実、全草等の部分が使用可能であるが、全草を用いるのが好ましい。
In the present invention, “inufuguri” means inuvenu (Veronica didyma Tenore) belonging to the genus Sphagnumaceae.
Inufufu can be used in parts such as leaves, stems, buds, flowers, seeds, fruits, whole plants, etc., but whole plants are preferably used.

斯かるイヌノフグリは、そのまま若しくはそれを圧搾することにより得られる搾汁、植物自身を乾燥した乾燥物若しくはその粉砕物、あるいはこれらから抽出した抽出物として用いることができるが、抽出物として用いるのが好ましい。   Such Inufuguri can be used as it is or as a squeezed juice obtained by squeezing it, a dried product obtained by drying the plant itself, or a pulverized product thereof, or an extract extracted therefrom. preferable.

抽出物としては、上記植物を常温又は加温下にて抽出するか又はソックスレー抽出器等の抽出器具を用いて抽出すること等公知の抽出方法により得られる各種溶剤抽出液、その希釈液、その濃縮液又はその乾燥末が挙げられる。
公知の抽出方法としては、例えば、浸漬、煎出、浸出、還流抽出、超臨界抽出、超音波抽出及びマイクロ波抽出等が挙げられる。
As the extract, various solvent extracts obtained by a known extraction method such as extraction of the above plant at room temperature or under heating, or extraction using an extractor such as a Soxhlet extractor, dilutions thereof, A concentrated solution or a dry powder thereof may be mentioned.
Known extraction methods include, for example, immersion, decoction, leaching, reflux extraction, supercritical extraction, ultrasonic extraction, and microwave extraction.

当該抽出物を得るために用いられる抽出溶剤としては、極性溶剤、非極性溶剤のいずれをも使用することができる。例えば、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;プロピレングリコール、ブチレングリコール等の多価アルコール類;アセトン、メチルエチルケトン等のケトン類;酢酸メチル、酢酸エチル等のエステル類;テトラヒドロフラン、ジエチルエーテル等の鎖状及び環状エーテル類;ポリエチレングリコール等のポリエーテル類;ジクロロメタン、クロロホルム、四塩化炭素等のハロゲン化炭化水素類;ヘキサン、シクロヘキサン、石油エーテル等の炭化水素類;ベンゼン、トルエン等の芳香族炭化水素類;ピリジン類等が挙げられ、これらは単独又は混合物として用いることができる。このうち、特に水、アルコール系(アルコール類及び/又は多価アルコール類(V/V))溶剤、及び水−アルコール系混合溶剤を用いるのが好ましく、水−アルコール系混合溶剤(V/V)が好ましい。さらに、アルコール系はアルコール類が好ましく、アルコール類のうちメタノール、エタノール、プロパノールがより好ましく、エタノールが特に好ましい。   As the extraction solvent used for obtaining the extract, either a polar solvent or a nonpolar solvent can be used. For example, water; alcohols such as methanol, ethanol, propanol and butanol; polyhydric alcohols such as propylene glycol and butylene glycol; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; tetrahydrofuran and diethyl ether Linear and cyclic ethers such as polyethylene; polyethers such as polyethylene glycol; halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride; hydrocarbons such as hexane, cyclohexane and petroleum ether; aroma such as benzene and toluene Group hydrocarbons; pyridines and the like, and these can be used alone or as a mixture. Among these, it is particularly preferable to use water, alcohol-based (alcohols and / or polyhydric alcohols (V / V)) solvents, and water-alcohol mixed solvents, and water-alcohol mixed solvents (V / V). Is preferred. Furthermore, alcohols are preferably alcohols, and among alcohols, methanol, ethanol, and propanol are more preferable, and ethanol is particularly preferable.

本発明のイヌノフグリ抽出物は、例えば、植物1質量部に対して1〜50質量部の抽出溶剤を用い、4〜100℃にて0.5時間〜30日間抽出することにより行うことができる。より具体的には、抽出溶剤として水を用いる場合には、植物1質量部に対して5〜30質量部、40〜100℃にて1時間〜1日間が好ましい。また、抽出溶剤として40〜60%エタノール水溶液を用いる場合には、植物1質量部に対して3〜20質量部、室温〜還流下、好ましくは20〜50℃の範囲にて、1時間〜20日間が好ましい。また、75〜100%エタノール水溶液を用いる場合には、植物1質量部に対して3〜20質量部、20℃〜還流下で1時間〜20日間が好ましい。   For example, the inuvenir extract of the present invention can be obtained by using 1 to 50 parts by mass of an extraction solvent with respect to 1 part by mass of a plant and extracting at 4 to 100 ° C. for 0.5 to 30 days. More specifically, when water is used as the extraction solvent, it is preferably 5 to 30 parts by mass and 40 to 100 ° C. for 1 hour to 1 day with respect to 1 part by mass of the plant. Moreover, when using 40-60% ethanol aqueous solution as an extraction solvent, it is 3-20 mass parts with respect to 1 mass part of plants, Room temperature-under reflux, Preferably it is 20-50 degreeC, It is 1 hour-20 Days are preferred. Moreover, when using 75-100% ethanol aqueous solution, 3-20 mass parts with respect to 1 mass part of plants, 20 hours-under reflux, 1 hour-20 days are preferable.

上記の抽出物は、そのまま用いることもできるが、当該抽出物を希釈、濃縮若しくは凍結乾燥した後、粉末又はペースト状に調製して用いることもできる。また、これら抽出処理物の他、市販品を用いても良い。   The above extract can be used as it is, but it can also be used by diluting, concentrating or lyophilizing the extract and preparing it in a powder or paste form. In addition to these extracted processed products, commercially available products may be used.

また、上記抽出物は、さらに液々分配、固液分配、濾過膜、活性炭、吸収樹脂、イオン交換樹脂等の公知の技術によって不活性な夾雑物を除去して用いることが好ましい。このとき用いる溶剤は、上記の抽出溶剤の例示のものを用いてもよい。また、これらは、必要により公知の方法により脱臭、脱色等の処理を施してから用いてもよい。また、抽出物をさらに精製する際には、当該公知の技術及び方法を用いてもよい。   The extract is preferably used after removing inactive impurities by a known technique such as liquid-liquid distribution, solid-liquid distribution, filtration membrane, activated carbon, absorption resin, ion exchange resin and the like. As the solvent used at this time, those exemplified for the extraction solvent may be used. Moreover, you may use these, after giving processes, such as a deodorizing and a decoloring, by a well-known method as needed. Moreover, when the extract is further purified, the known techniques and methods may be used.

後記実施例で示すとおり、本発明のイヌノフグリ抽出物は、インボルクリンの発現を促進する。インボルクリンの発現が促進されれば、角層形成が促進され、皮膚バリア機能を健全にすることができる。これにより、皮膚の水分保持能の改善(保湿効果)、毛穴目立ちの改善効果が期待される。また、インボルクリンの発現が促進されれば、毛髪をウェーブ化すること、或いはウェーブ化を促進することができると考えられる(前記特許文献1参照)。
よって、イヌノフグリ又はその抽出物は、インボルクリン発現促進剤、角層形成促進剤、保湿剤及び毛髪のウェーブ化剤となり得(以下、「インボルクリン発現促進剤等」という)、また、インボルクリン発現促進剤等を製造するために使用することができる。すなわち、ヒトに適用して、インボルクリンの発現促進又は角層形成促進、皮膚バリア機能の健全化、皮膚の水分保持能の改善(保湿作用)、しわの形成やきめ模様の減少等の皮膚老化の予防改善、毛穴目立ちの改善、毛髪のウェーブ化等のために使用することができる。
As shown in the Examples below, the Inufuguri extract of the present invention promotes the expression of involucrin. If the expression of involucrin is promoted, stratum corneum formation is promoted and the skin barrier function can be made healthy. Thereby, improvement of the moisture retention ability of the skin (moisturizing effect) and improvement effect of pore conspicuousness are expected. Further, if expression of involucrin is promoted, it is considered that hair can be waved or waved can be promoted (see Patent Document 1).
Accordingly, inufufu or an extract thereof can serve as an involucrin expression promoter, horny layer formation promoter, moisturizer, and hair waving agent (hereinafter referred to as “involucrin expression promoter, etc.”), involucrin expression promoter, etc. Can be used to manufacture. That is, when applied to humans, it promotes the expression of involucrin or promotes stratum corneum formation, improves the skin barrier function, improves the moisture retention ability of the skin (moisturizing action), reduces wrinkles and reduces texture, etc. It can be used for prevention improvement, improvement of pore conspicuity, hair waving and the like.

当該インボルクリン発現促進剤等は、それ自体、インボルクリンの発現促進、角層形成促進、皮膚の水分保持能の改善(保湿作用)、毛髪のウェーブ化のための、化粧品、医薬品、医薬部外品であってもよく、又は当該化粧品、医薬品、医薬部外品等に配合して使用される素材又は製剤であってもよい。   The involucrin expression promoters are cosmetics, pharmaceuticals and quasi drugs for promoting involucrin expression, promoting stratum corneum formation, improving skin moisture retention (moisturizing action), and waving hair. It may be a material or a preparation used in combination with the cosmetics, pharmaceuticals, quasi drugs and the like.

尚、「ウェーブ化」とは、直毛を、カールを有するカール毛とすること、或いは弱いカール毛を強いカール毛とすることをいい、カールの形状は縮毛、カール毛、強いウェーブ毛等の何れでもよい。   “Wave” means that the straight hair is curled hair having curls, or the weak curled hair is made strong curled hair, and the curled shape is curly hair, curled hair, strong wave hair, etc. Any of these may be used.

本発明のインボルクリン発現促進剤等を化粧品、医薬部外品又は医薬品等として使用する場合は、皮膚外用剤の形態で、具体的には、軟膏、乳化化粧料、クリーム、乳液、ローション、ジェル、エアゾール等の種々の形態で用いることが好ましい。当該皮膚外用剤は、通常の皮膚表面に使用する他に、脱毛処理後、さらには角層除去後の皮膚表面に使用してもよい。また、毛髪のウェーブ化のために使用する場合には、ヘアリンス、ヘアコンディショナー、ヘアトリートメント、ヘアローション、ヘアパック、ヘアクリーム、コンディショニングムース、ヘアムース、ヘアスプレー、シャンプー、リーブオントリートメント等の形態とすることができる。 斯かる上記製剤は、それぞれ一般的な製造法により、直接又は製剤上許容し得る担体、例えば、各種油剤、界面活性剤、ゲル化剤、防腐剤、酸化防止剤、溶剤、アルコール、水、キレート剤、増粘剤、紫外線吸収剤、乳化安定剤、pH調整剤、色素、香料等とともに混合、分散した後、所望の形態に加工することによって得ることができる。また、これらの化粧品、医薬部外品又は医薬品等には、本発明のイヌノフグリ又はその抽出物、それぞれの製剤に応じて、適宜、植物抽出物、鎮痛消炎剤、鎮痛剤、殺菌剤、収斂剤、皮膚軟化剤、ホルモン剤、ビタミン類、保湿剤、抗炎症剤、清涼剤、抗脂漏剤等を本発明の効果を妨害しない範囲で適宜配合することができる。   When the involucrin expression promoter of the present invention is used as cosmetics, quasi drugs or pharmaceuticals, it is in the form of an external preparation for skin, specifically, ointment, emulsified cosmetic, cream, emulsion, lotion, gel, It is preferably used in various forms such as aerosol. The external preparation for skin may be used on the surface of the skin after depilation and after removal of the stratum corneum, in addition to being used on the normal skin surface. When used for waving hair, it should be in the form of hair rinse, hair conditioner, hair treatment, hair lotion, hair pack, hair cream, conditioning mousse, hair mousse, hair spray, shampoo, leave-on treatment, etc. be able to. Such preparations are prepared according to general production methods, respectively, directly or pharmaceutically acceptable carriers such as various oils, surfactants, gelling agents, preservatives, antioxidants, solvents, alcohol, water, chelate. It can be obtained by mixing and dispersing together with an agent, a thickener, an ultraviolet absorber, an emulsion stabilizer, a pH adjuster, a dye, a fragrance and the like, and then processing into a desired form. In addition, for these cosmetics, quasi-drugs, pharmaceuticals, etc., the plant extracts, analgesic / anti-inflammatory agents, analgesics, bactericides, and astringents are appropriately selected according to the inuvenirs of the present invention or extracts thereof, and respective formulations. An emollient, a hormonal agent, vitamins, a moisturizer, an anti-inflammatory agent, a refreshing agent, an antiseborrheic agent and the like can be appropriately blended within a range that does not interfere with the effects of the present invention.

当該化粧品、医薬部外品又は医薬品等中の本発明のイヌノフグリ又はその抽出物の含有量は、一般的に固形分濃度として0.0005〜50質量%とするのが好ましく、0.001〜20質量%とするのがより好ましい。   In general, the content of the inuvenir of the present invention or the extract thereof in the cosmetic, quasi-drug or pharmaceutical product is preferably 0.0005 to 50% by mass as the solid content concentration, and 0.001 to 20%. It is more preferable to set it as the mass%.

上記医薬品、医薬部外品における本発明のイヌノフグリ又はその抽出物の投与量は、効果が得られる量であれば特に限定されず、対象者の状態、体重、性別、年齢又はその他の要因に従って変動し得るが、成人(60kg)1人当たり1日、イヌノフグリ又はその抽出物(乾燥物換算)として、例えば0.01〜1500mgとするのが好ましく、更に0.03〜600mgとするのが好ましい。また、当該製剤は、任意の摂取・投与計画に従って摂取・投与され得るが、1日1回〜数回に分け、数週間〜数カ月間継続して投与することが好ましい。
また、上記化粧品、医薬品又は医薬部外品の適用対象者としては、それを必要としていれば特に限定されないが、インボルクリンの発現促進、角層形成促進、皮膚バリア機能の健全化、皮膚の水分保持能の改善(保湿効果)、毛穴目立ちの改善、毛髪のウェーブ化を目的とするヒトが好ましい。
There is no particular limitation on the dose of the inovenge of the present invention or the extract thereof in the above-mentioned pharmaceuticals and quasi-drugs as long as the effect is obtained, and it varies according to the condition, weight, sex, age or other factors of the subject. However, it is preferably 0.01 to 1500 mg, and more preferably 0.03 to 600 mg, for example, as Inufuguri or an extract thereof (in terms of dry matter) per adult (60 kg) per day. The preparation can be ingested / administered according to any ingestion / administration plan, but is preferably divided into once to several times a day and continuously administered for several weeks to several months.
In addition, the application target of the above-mentioned cosmetics, pharmaceuticals or quasi drugs is not particularly limited as long as it is necessary, but it promotes expression of involucrin, promotion of stratum corneum formation, sound skin barrier function, retention of skin moisture Humans for the purpose of improving the performance (moisturizing effect), improving the conspicuous pores and making the hair wavy are preferred.

以下、実施例により本発明をさらに詳細に説明する。   Hereinafter, the present invention will be described in more detail with reference to examples.

製造例1 イヌノフグリ抽出物の製造
中国、四川省産のイヌノフグリ(Veronica didyma Tenore)全草の乾燥物200gに50% エタノール2000mLを加え、85℃加熱下、2時間浸漬後、ろ過した。ろ液後の残渣に50%エタノール2000mLを加え、再度85℃で1時間抽出を行った。ろ過後、2つのろ液をあわせ、減圧濃縮、乾燥してイヌノフグリ抽出物13gを得た。これを固形分1w/v%の50%エタノール溶液とし、評価エキスとした。
Production Example 1 Production of Inuvenufu Extract To 200 g dry product of Veronica didyma Tenore whole plant, Sichuan Province, China, 2000 mL of 50% ethanol was added, immersed in heating at 85 ° C. for 2 hours, and then filtered. To the residue after the filtrate, 2000 mL of 50% ethanol was added, and extraction was performed again at 85 ° C. for 1 hour. After filtration, the two filtrates were combined, concentrated under reduced pressure, and dried to obtain 13 g of Inufugururi extract. This was made into a 50% ethanol solution with a solid content of 1 w / v%, and used as an evaluation extract.

実施例1 インボルクリン発現促進作用
インボルクリンのタンパク質量定量にはInvolucrin ELISA Assay Kit(BT-650, BTI)を使用した。
24穴プレートにHaCaT細胞を5×104個/ウェルにて播種し、培養した。翌日、製造例1で得られたイヌノフグリ抽出物を終濃度0.5% v/vを含む培地に交換して更に24時間培養した。抽出物添加から24時間後、細胞をPBS(ギブコ)で2回洗浄し、20mM Tris-HCl(pH:7.5)・2mM EDTAにComplete Mini Protease Inhibitor Cocktail(Roche)を含むbuffer、400μlを細胞に添加した。Protease Inhibitor Cocktailはbuffer 10mlに対して1粒加えた。このbuffer存在下でセルスクレーパーにより、細胞を剥離・回収した後、ソニケーターによる超音波処理を行った。この溶液を遠心して回収した上清をライセートとして評価に用いた。
Example 1 Involucrin expression promoting action Involucrin ELISA Assay Kit (BT-650, BTI) was used for quantifying the protein content of involucrin.
A 24-well plate was seeded with HaCaT cells at 5 × 10 4 cells / well and cultured. On the next day, the Inufufu extract obtained in Production Example 1 was replaced with a medium containing a final concentration of 0.5% v / v and further cultured for 24 hours. 24 hours after the addition of the extract, the cells were washed twice with PBS (Gibco), and 400 μl of a buffer containing Complete Mini Protease Inhibitor Cocktail (Roche) in 20 mM Tris-HCl (pH: 7.5) and 2 mM EDTA was added to the cells. did. One Protease Inhibitor Cocktail was added to 10 ml of buffer. Cells were detached and collected with a cell scraper in the presence of this buffer, and then sonicated with a sonicator. The supernatant collected by centrifugation of this solution was used as an lysate for evaluation.

ライセートの総タンパク質濃度はBCA Protein Assay Kit(Thermo Scientific)を用いてメーカーの使用説明書に従って、定量した。96穴プレートの1ウェルに対し、3μgの総タンパク質量となるようにライセートをbuffer B(2mM EDTA、5g/L Tween 20、2.5g/L Gelatin in PBS)で希釈し、96穴プレートに添加した後、抗インボルクリン抗体(キット付属品、希釈率1/300)を加えて4℃で一晩1次抗体反応を行った。   The total protein concentration of the lysate was quantified using BCA Protein Assay Kit (Thermo Scientific) according to the manufacturer's instructions. The lysate was diluted with buffer B (2 mM EDTA, 5 g / L Tween 20, 2.5 g / L Gelatin in PBS) to a total well of 3 µg per well of a 96-well plate and added to the 96-well plate Then, an anti-involucrin antibody (kit accessory, dilution ratio 1/300) was added and a primary antibody reaction was performed overnight at 4 ° C.

また、別の96穴プレート(ナルジェヌンク)にヒトインボルクリンタンパク質(キット付属品)を1ng/wellずつ添加し、縮合剤であるEDC(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide、関東化学)10μg/wellと共に、4℃で一晩抗原の吸着を行った。翌日、抗原を吸着させたプレートの溶液を吸引除去し、100μlの0.1M NH4Clを添加して30分間室温で反応させた。反応後、distilled H2O(ギブコ)で4回、buffer Bで1回洗浄し、前日の1次抗体反応液100μlを添加して30分間室温で反応させた。この反応の後、buffer Bで5回洗浄し、キット付属の抗ウサギ-AP Conjugate抗体(希釈率1/2000)を添加して室温で1時間反応させた。反応後、buffer Bで4回、buffer D(1mM MgCl2.6H2O in 0.05M carbonate/bicarbonate(シグマ)で1回洗浄し、p-nitrophenylphosphate(1mg/ml in buffer D、シグマ)溶液を100μl添加して発色反応を行った。発色が確認された後、405nmの吸光度を測定し、インボルクリンタンパク質量を定量した。コントロール(抽出物無添加)におけるインボルクリン発現量を1.0とした時の発現量相対値を求めた。結果を図1に示す。 In addition, human involucrin protein (supplied with the kit) is added to another 96-well plate (Narugenunk) at a rate of 1 ng / well, and EDC (1-ethyl-3- (3-dimethylaminopropyl) carbodiimide, Kanto Chemical) 10 μg as a condensing agent Along with / well, antigen was adsorbed overnight at 4 ° C. On the next day, the solution of the plate on which the antigen was adsorbed was removed by aspiration, and 100 μl of 0.1M NH 4 Cl was added and allowed to react at room temperature for 30 minutes. After the reaction, the plate was washed 4 times with distilled H 2 O (Gibco) and once with buffer B, and 100 μl of the primary antibody reaction solution of the previous day was added and reacted at room temperature for 30 minutes. After this reaction, the plate was washed 5 times with buffer B, and the anti-rabbit-AP Conjugate antibody (dilution ratio 1/2000) attached to the kit was added and reacted at room temperature for 1 hour. After the reaction, 4 times with buffer B, then washed once with buffer D (1mM MgCl 2 .6H 2 O in 0.05M carbonate / bicarbonate ( Sigma), p-nitrophenylphosphate (1mg / ml in buffer D, Sigma) solution 100μl After the color development was confirmed, the absorbance at 405 nm was measured to determine the amount of involucrin protein.The expression level relative to the involucrin expression level in the control (no extract added) was 1.0. Values were determined and the results are shown in FIG.

図1から明らかなように、イヌノフグリ抽出物は、優れたインボリクリン発現促進作用を有していた。   As is clear from FIG. 1, the Inufufu extract had an excellent inboliclin expression promoting effect.

Claims (5)

イヌノフグリ又はその抽出物を有効成分とするインボルクリン発現促進剤。   An involucrin expression promoting agent comprising inuvenufu or an extract thereof as an active ingredient. イヌノフグリ又はその抽出物を有効成分とする角層形成促進剤。   A stratum corneum formation promoter containing inuinufugu or an extract thereof as an active ingredient. イヌノフグリ又はその抽出物を有効成分とする保湿剤。   A moisturizing agent containing inofuguri or an extract thereof as an active ingredient. イヌノフグリ又はその抽出物を有効成分とする毛髪ウェーブ化剤。   A hair waving agent containing inunovuri or an extract thereof as an active ingredient. イヌノフグリ又はその抽出物を含有する皮膚外用剤。   An external preparation for skin containing Inufuguri or an extract thereof.
JP2011236255A 2011-10-27 2011-10-27 Involucrin expression promoter Active JP5858727B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011236255A JP5858727B2 (en) 2011-10-27 2011-10-27 Involucrin expression promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011236255A JP5858727B2 (en) 2011-10-27 2011-10-27 Involucrin expression promoter

Publications (2)

Publication Number Publication Date
JP2013091632A true JP2013091632A (en) 2013-05-16
JP5858727B2 JP5858727B2 (en) 2016-02-10

Family

ID=48615060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011236255A Active JP5858727B2 (en) 2011-10-27 2011-10-27 Involucrin expression promoter

Country Status (1)

Country Link
JP (1) JP5858727B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018186060A1 (en) * 2017-04-04 2018-10-11 味の素株式会社 Compound, composition, and moisturizing agent
WO2019135566A1 (en) * 2018-01-03 2019-07-11 의료법인 성광의료재단 Skin aging-specific epigenetic gene marker and skin aging detection method using same
KR20190116231A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by increased formation of skin wrinkles
KR20190116229A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 PCR primer set for detecting skin aging-specific Epigenetic gene markers
KR20190116230A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by skin photoaging
KR20190116232A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by increased thickness of skin epithelial cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07309770A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic
DE19729143A1 (en) * 1997-07-08 1999-01-14 Uwe Fischer Herbal ointment for treating dry, flaky skin
JP2000143437A (en) * 1998-11-09 2000-05-23 Ichimaru Pharcos Co Ltd Cosmetic composition containing huhectant vegetable extract
JP2010070496A (en) * 2008-09-18 2010-04-02 Tsumura Lifescience Co Ltd Agent for promoting production of hair and/or hair follicle reinforcing factor
WO2011043330A1 (en) * 2009-10-05 2011-04-14 花王株式会社 Hair shape susceptibility gene

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07309770A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic
DE19729143A1 (en) * 1997-07-08 1999-01-14 Uwe Fischer Herbal ointment for treating dry, flaky skin
JP2000143437A (en) * 1998-11-09 2000-05-23 Ichimaru Pharcos Co Ltd Cosmetic composition containing huhectant vegetable extract
JP2010070496A (en) * 2008-09-18 2010-04-02 Tsumura Lifescience Co Ltd Agent for promoting production of hair and/or hair follicle reinforcing factor
WO2011043330A1 (en) * 2009-10-05 2011-04-14 花王株式会社 Hair shape susceptibility gene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015026975; 世界有用植物事典 , 19890825, p.1087,1088 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018186060A1 (en) * 2017-04-04 2018-10-11 味の素株式会社 Compound, composition, and moisturizing agent
WO2019135566A1 (en) * 2018-01-03 2019-07-11 의료법인 성광의료재단 Skin aging-specific epigenetic gene marker and skin aging detection method using same
KR20190083223A (en) * 2018-01-03 2019-07-11 의료법인 성광의료재단 Skin aging-specific Epigenetic gene markers and detection method of skin aging using them
KR102032540B1 (en) 2018-01-03 2019-10-15 의료법인 성광의료재단 Skin aging-specific Epigenetic gene markers and detection method of skin aging using them
KR20190116231A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by increased formation of skin wrinkles
KR20190116229A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 PCR primer set for detecting skin aging-specific Epigenetic gene markers
KR20190116230A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by skin photoaging
KR20190116232A (en) * 2019-10-07 2019-10-14 의료법인 성광의료재단 Diagnosis for skin aging caused by increased thickness of skin epithelial cells
KR102039176B1 (en) 2019-10-07 2019-10-31 의료법인 성광의료재단 Diagnosis for skin aging caused by increased formation of skin wrinkles
KR102039177B1 (en) 2019-10-07 2019-10-31 의료법인 성광의료재단 Diagnosis for skin aging caused by increased thickness of skin epithelial cells
KR102039175B1 (en) 2019-10-07 2019-10-31 의료법인 성광의료재단 Diagnosis for skin aging caused by skin photoaging
KR102039174B1 (en) 2019-10-07 2019-10-31 의료법인 성광의료재단 PCR primer set for detecting skin aging-specific Epigenetic gene markers

Also Published As

Publication number Publication date
JP5858727B2 (en) 2016-02-10

Similar Documents

Publication Publication Date Title
JP5858727B2 (en) Involucrin expression promoter
JP2007277149A (en) Involucrin expression promoter
JP2006124350A (en) Nmf production promoter
JP2015027998A (en) Moisturizer, skin barrier function activator, tight junction formation accelerator, trpv4 expression enhancer, intracellular calcium concentration increaser, intracellular calcium concentration increaser, lipid synthesis accelerator, blood flow improver and periocular darkness ameliorator
JP5858726B2 (en) Involucrin expression inhibitor
JP6338107B2 (en) Skin barrier function improving agent, intercellular adhesion structure formation promoter, tight junction formation promoter, and TRPV4 gene expression enhancer
JP2010184916A (en) Hair growth promoter
JP5903251B2 (en) Involucrin expression promoter
JP2006131558A (en) Collagen formation enhancer
JP2009242310A (en) Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous
JP2002284648A (en) Composition for hair restorer
JP6386761B2 (en) Involucrin expression inhibitor
JP6434180B1 (en) Elastic fiber formation promoter
JP2001206822A (en) Cosmetic for hair
JP2000239145A (en) Anti-allergic agent, beautifully whitening agent and skin cosmetic
JP7246125B2 (en) Epidermal cell activator
JP2015093848A (en) Skin cosmetic and hair cosmetic
JP2005139141A (en) Collagen synthesis promoter and external preparation for the skin
KR102468538B1 (en) Skin improvement composition containing wild geranium extract with excellent antioxidant, whitening and anti-inflammatory effects
KR102501845B1 (en) Composition for skin regeneration and wound healing comprising the extract of Cynanchum wilfordii as an active ingredient
JP5993724B2 (en) Elastin production promoter and skin cosmetics
JP4589799B2 (en) Hair restorer
JP4113518B2 (en) TGF-β production promoter for suppressing hair growth of body hair
JP4391043B2 (en) Hair nourishing agent containing Nanyang purple extract
JP2002068931A (en) Composition for external use

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141002

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150707

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150907

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151215

R151 Written notification of patent or utility model registration

Ref document number: 5858727

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250